Targeting HEDGEHOG Signaling and BRD4 for Melanoma Treatment | Oncotarget



July 18, 2023

  • Share
  • Oncotarget published this trending editorial on May 26, 2023 in Volume 14, entitled, “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" by Silvia Pietrobono and Barbara Stecca from the Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, Italy; Core Research Laboratory, Institute for Cancer Research and Prevention (CRL-ISPRO), Florence, Italy. DOI - Correspondence to - Silvia Pietrobono -, and Barbara Stecca - Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Oncotarget - Keywords - cancer, melanoma, hedgehog signaling, BRD4, SOX2, GLI1 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit and connect with us: SoundCloud - Facebook - Twitter - Instagram - YouTube - LinkedIn - Pinterest - Reddit - Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer Research

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.